IDEAYA Biosciences ($IDYA) Insider Trading & Smart Money Activity
IDEAYA Biosciences, Inc. ($IDYA) has 5 insider trades, 1 13F position change and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($985.40K), net -$985.40K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$985.40K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 1
- Analyst ratings on file
- 1
IDYA insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 1 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $985.40K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IDYA insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Hata Yujiro SPresident and CEO | Sell (Open-market sale) 10b5-1 | 26.34K sh | $985.40K | -6.5% | — | |||||
| Insider | Wendy Yarno | Buy (Grant or award) | 20K sh | +14.2% | +17.5% | — | |||||
| Insider | Terry Rosen | Buy (Grant or award) | 20K sh | +14.2% | +17.5% | — | |||||
| Insider | Catherine Mackey | Buy (Grant or award) | 20K sh | +14.2% | +17.5% | — | |||||
| Insider | Hampton Malcolm Garret | Buy (Grant or award) | 20K sh | +14.2% | +17.5% | — | |||||
| Analyst | Wedbush | Reiterates to buy | PT $58 | +18.1% | +24.7% | Read | |||||
| 13F | Baker Bros. Advisors | Added | +327.69K sh | $147.09M | +3.2% | +7.2% | — |
1W / 1M / 6M = how IDYA moved from the trade or filing date.
Insider trading in IDYA: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Hata Yujiro S | President and CEO | 1 | -$985.40K | Oct 6, 2026 | |
| Wendy Yarno | 1 | — | Jun 16, 2026 | ||
| Terry Rosen | 1 | — | Jun 16, 2026 | ||
| Catherine Mackey | 1 | — | Jun 16, 2026 | ||
| Hampton Malcolm Garret | 1 | — | Jun 16, 2026 |
Institutions moving IDYA (13F)
Analyst ratings on IDYA
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Wedbush | Reiterates | buy | $58 | +18.1% | +24.7% | Read |
Frequently asked questions
Are IDYA insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $985.40K, a net -$985.40K.
What is the latest insider trade in IDYA?
Hata Yujiro S, President and CEO filed a sell (open-market sale) of 26.34K sh worth $985.40K on Oct 6, 2026.
Which institutions changed their IDYA positions?
Recent 13F filers moving the stock include Baker Bros. Advisors.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.